Table 1 Clinical data of patients
Rheumatoid arthritis | |||||||
|---|---|---|---|---|---|---|---|
Patient | Gender/age (years) | Disease duration (years) | RF | ESR (mm/h) | CRP (mg/ml) | No. of ARA criteria | Concurrent treatment |
EB 73 | M/68 | 8 | + | 90 | 48.1 | 6 | MTX |
EB 74 | F/71 | 17 | + | 45 | 26.9 | 6 | NSAIDs |
EB 87 | F/65 | 12 | + | 50 | 106.7 | 5 | NSAIDs |
EB 88 | F/62 | 10 | + | 90 | 169.5 | 6 | NSAIDs |
EB 96 | M/67 | 4 | + | 68 | 75.7 | 4 | NSAIDs |
EB 108 | F/72 | 45 | + | 70 | 70.7 | 7 | NSAIDs, steroids |
EB 141 | F/73 | 1 | + | 57 | 14.3 | 5 | NSAIDs, steroids |
Osteoarthritis | |||||||
EB 77 | F/66 | 5 | - | 2 | <5.0 | 0 | None |
EB 81 | F/56 | 3 | - | 14 | <5.0 | 0 | None |
EB 90 | F/61 | 2 | - | 18 | <5.0 | 0 | None |
EB 102 | F/73 | 8 | - | 20 | <5.0 | 0 | NSAIDs |
EB 115 | F/56 | 3 | - | 11 | 8.2 | 0 | NSAIDs |
EB 118 | M/72 | 2 | - | 4 | 9.3 | 0 | NSAIDs |
EB 135 | M/57 | 4 | - | 12 | <5.0 | 0 | NSAIDs |
EB 165 | F/63 | 3 | - | 11 | 6.1 | 0 | NSAIDs |
EB 172 | M/61 | 3 | - | 5 | <5.0 | 0 | NSAIDs |